Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Internet Broadcast Project grabs attention of Commonwealth – and yet another award
2015-07-28


 
Learn more about the Internet Broadcast Project and its impact on learners’ lives

The Internet Broadcast Project (IBP) has brought yet another international award to the University of the Free State (UFS). This project – which is changing the lives of Free State school learners – has won second place in the Commonwealth Education Good Practice Awards, a huge achievement considering that the IBP was chosen from 89 submissions entered by a total of 20 countries belonging to the Commonwealth.

This latest award comes close on the heels of another international award that was presented to the IBP recently. In April 2015, the project was the winner of the 2015 Enterprise Video Award (EVA) in the category Video in Education Scholarship. This makes it two in a row, since the IBP also won an EVA in 2014 for Innovation in Pedagogy.

 

Mr Kamalesh Sharma, Secretary General of the Commonwealth Secretariat, presenting the second-place prize for the Commonwealth Good Practice Awards to Sarietjie Musgrave, Head: ICTISE (ICT in School Education) on behalf of ICTISE.
Photo: Peter Ramsay

Live broadcast at no cost to schools
The IBP – presented from the UFS South Campus – makes use of the best teachers to broadcast lessons to school learners who do not have access to quality education. More than 10 subjects are broadcast live, via VSAT Internet Access, to 70 centres across the province. The technology provided at each school allows learners to communicate with the presenter in the studio during broadcast at no cost to the school or learner.

“Through the IBP,” says Sarietjie Musgrave, Head: ICTISE (ICT in School Education), “we aim to bring quality education to each and every learner, regardless of their socio-economic status or geographical location, while delivering cost-effective continuous teacher professional development directly relevant to the Free State community we serve.”

Making a positive difference
The Commonwealth Education Good Practice Awards honour education programmes that have made a positive difference to the status and condition of school children, teachers, or the education system in their countries. The IBP was lauded for its excellence in six of the Action Areas of Good Practices:

• Relevance
• Measurable impact and effect
• Sustainability
• Efficiency and effectiveness
• Community participation
• Replication

“Receiving this international award,” says Musgrave, “shows that we are having an impact worldwide.”

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept